
No Benefit From Routine Thyroid Cancer Screening: Task Force
TUESDAY, Nov. 22, 2016 (HealthDay News) -- Doctors should not screen for thyroid cancer in patients who have no symptoms of the disease, according to a U.S. Preventive Services Task Force draft recommendation.
It reaffirms a recommendation issued 20 years ago.
Thyroid cancer is rare in the United States. In 2016, an estimated 64,300 new cases will be diagnosed, representing 3.8 percent of all new cancers. The thyroid is a small gland in the neck that play a key role in controlling metabolism.
"While there is very little evidence of the benefits of screening for thyroid cancer, there is considerable evidence of the significant harms of treatment," said task force member Karina Davidson. She is director of the Center for Behavioral Cardiovascular Health at Columbia University Medical Center in New York City.
"And in the places where universal screening has been tried, it hasn't helped people live longer, healthier lives," she added in a task force news release.
Studies from several countries suggest widespread thyroid cancer screening leads to overdiagnosis, said task force chairwoman Dr. Kirsten Bibbins-Domingo. She is a professor of medicine, epidemiology and biostatistics at the University of California, San Francisco.
"People who are treated for small or slow-growing tumors are exposed to risks from surgery or radiation, but do not receive any benefit because the tumors are unlikely to affect the person's health during their lifetime," she said in the news release.
The task force is accepting public comments on the draft recommendation through Dec. 26.
The task force is an independent, volunteer panel made up of U.S. experts in prevention and evidence-based medicine.
-- Robert Preidt
Article Credits / Source
Sponsored Product
More Cancer Articles
Depressed Women Less Likely to Get Best Breast Cancer Care: Study0
FRIDAY, Nov. 18, 2016 (HealthDay News) -- Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with ...
Earnings Fall After a Child's Cancer Diagnosis0
MONDAY, Nov. 21, 2016 (HealthDay News) -- After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' ...
Monoclonal Antibodies0
home / cancer center / cancer a-z list / monoclonal antibodies index / monoclonal antibodies drug monograph Pharmacy Author: Omudhome Ogbru, PharmD Omudhome Ogbru, PharmDDr. Ogbru received his ...
New Drug May Brighten Outlook for Advanced Breast Cancer0
WEDNESDAY, Nov. 16, 2016 (HealthDay News) -- A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year ...
Exercise Good for Cancer Patients During, After Treatment0
TUESDAY, Nov. 15, 2016 (HealthDay News) -- Exercising during and after cancer treatment is safe and improves quality of life, fitness and physical functioning, new research indicates. Benefits occurred with all types of exercise, said study ...
0 Comments
Write a Comment
Tag Cloud
Our Mailing List
Subscribe to our mailing list to get the latest health news as it breaks!
Author
The full comment or 255 characters
View Article➦